Literature DB >> 22535775

Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.

Suganya Selvarajah1,2, Sheila Keating1,2, John Heitman2, Kai Lu2, Graham Simmons1,2, Philip J Norris3,1,2, Eva Operskalski4, James W Mosley4, Michael P Busch1,2.   

Abstract

Prior to the identification of hepatitis C virus (HCV), transfusion-transmission was common. Viral transmission in subjects with a known date of infection allows the study of the immune responses to acute HCV infection. We analysed 39 soluble immune factors in serum samples from subjects with transfusion-transmitted HCV. Dynamic expression kinetics of interferon gamma-induced protein 10 (IP-10), tumour necrosis factor-alpha and interleukin (IL)-10 were observed during acute HCV infection. Serum IP-10 was the only analyte that was significantly elevated in HCV resolvers compared with uninfected controls. In individuals who progressed to chronic HCV elevated levels of IP-10 and IL-10 coincided with first significant alanine aminotransferase elevation and remained elevated during the first year of acute HCV infection. In addition to monitoring lack of reduction in viral load, serum levels of IP-10 and IL-10 expression during acute HCV infection may be useful biomarkers to predict the progress to chronic HCV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535775      PMCID: PMC3541758          DOI: 10.1099/vir.0.041277-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

Review 1.  The global burden of hepatitis C.

Authors:  Daniel Lavanchy
Journal:  Liver Int       Date:  2009-01       Impact factor: 5.828

2.  Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.

Authors:  Suguru Yoneda; Takeji Umemura; Yoshihiko Katsuyama; Atsushi Kamijo; Satoru Joshita; Michiharu Komatsu; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
Journal:  J Infect Dis       Date:  2011-03-11       Impact factor: 5.226

3.  Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

Authors:  J K Flynn; G J Dore; M Hellard; B Yeung; W D Rawlinson; P A White; J M Kaldor; A R Lloyd; R A Ffrench
Journal:  J Viral Hepat       Date:  2010-07-05       Impact factor: 3.728

4.  Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

Authors:  Marija Zeremski; Giles Hooker; Marla A Shu; Emily Winkelstein; Queenie Brown; Don C Des Jarlais; Leslie H Tobler; Barbara Rehermann; Michael P Busch; Brian R Edlin; Andrew H Talal
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

6.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

Authors:  Claire Dunn; Dimitra Peppa; Pooja Khanna; Gaia Nebbia; Meleri Jones; Nathan Brendish; R Monica Lascar; David Brown; Richard J Gilson; Richard J Tedder; Geoffrey M Dusheiko; Michael Jacobs; Paul Klenerman; Mala K Maini
Journal:  Gastroenterology       Date:  2009-07-07       Impact factor: 22.682

7.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

Authors:  Marija Zeremski; Rositsa Dimova; Queenie Brown; Ira M Jacobson; Marianthi Markatou; Andrew H Talal
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

9.  Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.

Authors:  Emma C Thomson; Vicki M Fleming; Janice Main; Paul Klenerman; Jonathan Weber; Joseph Eliahoo; Jennifer Smith; Myra O McClure; Peter Karayiannis
Journal:  Gut       Date:  2010-12-07       Impact factor: 23.059

10.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  5 in total

Review 1.  Transfusion transmission of HCV, a long but successful road map to safety.

Authors:  Suganya Selvarajah; Michael P Busch
Journal:  Antivir Ther       Date:  2012-12-07

2.  Postnatal persistent infection with classical Swine Fever virus and its immunological implications.

Authors:  Sara Muñoz-González; Nicolas Ruggli; Rosa Rosell; Lester Josué Pérez; Maria Teresa Frías-Leuporeau; Lorenzo Fraile; Maria Montoya; Lorena Cordoba; Mariano Domingo; Felix Ehrensperger; Artur Summerfield; Llilianne Ganges
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

3.  Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.

Authors:  Behzad Hajarizadeh; François Mj Lamoury; Jordan J Feld; Janaki Amin; Elizabeth Keoshkerian; Gail V Matthews; Margaret Hellard; Gregory J Dore; Andrew R Lloyd; Jason Grebely; Tanya L Applegate
Journal:  Virol J       Date:  2016-02-24       Impact factor: 4.099

4.  Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection.

Authors:  Jordan J Feld; Jason Grebely; Gail V Matthews; Tanya Applegate; Margaret Hellard; Alana Sherker; Vera Cherepanov; Kathy Petoumenos; Barbara Yeung; John M Kaldor; Andrew R Lloyd; Gregory J Dore
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

5.  African swine fever virus infection in Classical swine fever subclinically infected wild boars.

Authors:  Oscar Cabezón; Sara Muñoz-González; Andreu Colom-Cadena; Marta Pérez-Simó; Rosa Rosell; Santiago Lavín; Ignasi Marco; Lorenzo Fraile; Paloma Martínez de la Riva; Fernando Rodríguez; Javier Domínguez; Llilianne Ganges
Journal:  BMC Vet Res       Date:  2017-08-01       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.